Previously submitted to: JMIR Mental Health (no longer under consideration since Dec 17, 2025)
Date Submitted: Dec 16, 2025
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Automated Mood Detection from Naturalistic Phone Conversations: A Feasibility Study for Relapse Prediction in Mood Disorders
ABSTRACT
Background:
Mood disorders have high relapse rates and existing monitoring relies on infrequent clinical assessments and self-report, limiting timely intervention
Objective:
To evaluate the feasibility of a smartphone-based system that passively infers mood from naturalistic phone conversations using speech signal processing and artificial intelligence, and to examine alignment with self-reported mood and clinical measures
Methods:
We deployed a background smartphone app to capture speech during routine calls and prompted post-call mood ratings. Encrypted features (speaker diarisation, prosody, Mel-Frequency Cepstral Coefficients (MFCCs), Word2Vec embeddings) were processed on secure servers. Phase 1 validated inferred mood against post-call self-ratings; Phase 2 compared daily mood trajectories with the Montgomery–Åsberg Depression Rating Scale (MADRS) and Early Warning Signs Questionnaire (EWSQ). The MADRS, routinely used in the hospital service, was employed to maintain continuity with clinical practice and minimise disruption to workflows.
Results:
Eleven participants completed Phase 1. The inferred mood demonstrated a moderate correlation with self-reported ratings, with performance improving as call volumes increased. The pipeline operated across heterogeneous devices and preserved privacy via feature-vector transmission
Conclusions:
Speech-based mood inference from naturalistic phone calls is feasible and aligns with subjective and clinical indicators, especially with sufficient call activity. Privacy-preserving design and multimodal features facilitate real-world deployment while promoting proactive relapse prevention. Clinical Trial: No Trial
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.